The field of diabetes care is continually moving forward. Even as data was being presented at this year's meeting of the American Diabetes Association the future was at the forefront of many people's minds in an effort to help these patients even more.
There is no question that hunger can affect a person's life, a recent study looked at the scientific aspect of this discussion and what doctors can do to help patients with this challenge.
The obesity epidemic continues to grow in this country leaving the medical community to find new ways to help this patient population.
A fair amount of women who are diagnosed with gestational diabetes take active measures to lose weight – but what clinical outcomes does that have?
What happens when a patient with type 2 diabetes uses both a potassium (K)-sparing agent and sodium-glucose co-transporter 2 (SGLT2) inhibitor at the same time?
Acknowledging that uncertainty is a key factor in the care and treatment of multiple sclerosis is part of a solution to a problem, finding the best way to deal with that uncertainty is another issue that must be confronted by patients and doctors alike.
From the time a patient is diagnosed with multiple sclerosis there are often more questions than answers for extended periods of time. What that means for their care and management of symptoms is the subject of a recent study.
A recently concluded survey looked at issues most affecting patients with multiple sclerosis that they may not have been willing or able to discuss with health care providers but could help others with the condition in the future.
Even as the number of medications approved to treat relapsing remitting multiple sclerosis continues to grow patients with progressive forms of the condition still await the first approved treatment option to help manage their symptoms.
Research into the inner workings of multiple sclerosis comes in all shapes and sizes including looking at specific parts of the brain. A recent study has looked at the role of the blood brain barrier and how it affects patients with this condition.
Country music artist, Clay Walker – who is well-known for his hit songs “She Won’t Be Lonely Long†and “Live Until I Die" – was diagnosed with a relapsing form of multiple sclerosis (MS) at the age of 26.
While newly approved treatments for multiple sclerosis move away from interferon based medications Rebif continues to be a popular choice after more than a decade in the field.
The treatment of multiple sclerosis requires the work of more than just neurologists and that figures to be the case well into the future as well.
Marijuana and alcohol – studies suggest that one of these substances helps patients with multiple sclerosis while the other can contribute to comorbidities.
Lifestyle factors and multiple sclerosis is a two-way street; but what does that mean for practicing physicians? Allen Bowling, MD, PhD, explains at the 2016 Annual Meeting of the Consortium of Multiple Sclerosis Center (CMSC) in National Harbor, Maryland.
Disease-modifying therapies (DMTs) help reduce relapses in people with multiple sclerosis. While options have expanded, little is known about which one has the greatest effectiveness.
A phase III study that examined teriflunomide (Aubagio) in a subtype of patients with multiple sclerosis was presented at the 2016 Annual Meeting of the Consortium of Multiple Sclerosis Center (CMSC) in National Harbor, Maryland.
Cataracts are one of the most common diagnosis in eye care but there is still work being done to help treat the condition in the most effective way possible.
For people who may not know what borderline personality disorder is or have questions about what can be done to help these patients a new effort is being made to raise awareness about this difficult condition.
The Nazi criminals' crimes against humanity continue to stun psychiatrists. Was there a neurological defect involved?
Modern medicine focuses too much on extending life and too little on making sure that's the kind of life patients want. Using conversational skills like those of psychiatrists, that can change for the better.
Do patients diagnosed with anxiety disorder experience a greater burden of metabolic disorders such as diabetes and hyperlipidemia?
Although Lyme disease typically impacts the skin, joints, and heart, it can also cause a variety of neurologic and psychiatric complications for which there are no current treatment guidelines.
Yutao Liu, MD, PhD, Georgia Regents University, discussed how he and his team can potentially target genes to either reduce glaucoma or provide neuroprotection specifically for the mitochondria in the retina.
Henry Kaplan, MD, KY Lions Eye Center, University of Louisville School of Medicine, is focusing his efforts on figuring out how to preserve or recover lost central vision in patients with retinitis pigmentosa.
Neeraj Agarwal, PhD, FARVO, shared his unique perspective of marrying his prior clinical research to his current institutional landscape at the NIH.
Andrew Hartwick, PhD, The College of Optometry at The Ohio State University wants to understand why regardless of normal, standard vision tests, there is still clearly something wrong with pateints' sight.
Aflibercept exerts anti-angiogenic effects against galectin-1, a galactoside-binding lectin protein and novel angiogenic factor associated with proliferative diabetic retinopathy.
Patients with the hereditary degenerative eye disease retinitis pigmentosa (RP) may delay their loss of daytime vision by taking a traditional Chinese plant remedy Lycium barbarum also known as goji berry or wolfberry.
A battery-operated Liftware utensil was developed in 2014 to help Parkinson’s disease patients manage their hand tremors and conquer daily activities.
